PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $798,000 | -60.7% | 10,459 | -63.9% | 0.01% | -52.9% |
Q1 2021 | $2,032,000 | +17.1% | 29,000 | 0.0% | 0.02% | +30.8% |
Q4 2020 | $1,735,000 | +275.5% | 29,000 | +208.5% | 0.01% | +160.0% |
Q3 2018 | $462,000 | +0.2% | 9,400 | -34.7% | 0.01% | -16.7% |
Q2 2018 | $461,000 | -52.9% | 14,400 | -54.1% | 0.01% | -53.8% |
Q1 2018 | $978,000 | +155.4% | 31,400 | +273.8% | 0.01% | +225.0% |
Q4 2017 | $383,000 | -52.5% | 8,400 | -66.4% | 0.00% | -60.0% |
Q4 2016 | $807,000 | – | 25,000 | +49900.0% | 0.01% | – |
Q3 2013 | $0 | -100.0% | 50 | 0.0% | 0.00% | -100.0% |
Q2 2013 | $21,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |